Holographic Surgery Gives 79-Year-Old a 'Second Life' After Terminal Cancer
Holographic Surgery Gives 79-Year-Old a 'Second Life' After Terminal Cancer
Operation with 3D Image - How a Senior Defeated Cancer - Holographic Surgery Gives 79-Year-Old a 'Second Life' After Terminal Cancer
A 79-year-old woman once considered beyond treatment has made a remarkable recovery thanks to cutting-edge holographic surgery. Antonie Deussen, diagnosed with advanced colorectal cancer that had spread to her liver, underwent a pioneering procedure at Pius Hospital in Oldenburg. Her case marks one of the first successful uses of holographic medicine in a clinical study.
Doctors initially gave Deussen little hope after her cancer reached an advanced stage. Her son, unwilling to accept the grim prognosis, researched alternative treatments and discovered the holographic medicine programme at the Oldenburg clinic.
The technology works by converting radiological scans into interactive 3D holograms using specialised glasses and software. Surgeons can then examine tumours in greater detail, improving precision during operations. Pius Hospital is one of only five centres worldwide equipped with this system.
Deussen agreed to participate in the study despite the risks. The surgery proved successful, and her health improved dramatically afterward. She later described the outcome as a 'second life'.
As of March 2026, no additional centres beyond the initial five have been publicly confirmed to use this specific holographic technology. No global database tracks further implementations or their locations.
Deussen's recovery highlights the potential of holographic medicine in treating complex cancers. The procedure remains rare, with only a handful of certified centres currently offering it. Her case provides concrete evidence of how advanced imaging can change outcomes for patients once deemed untreatable.
Scientists discover a shared weakness in deadly gut bacteria for a universal vaccine
A hidden flaw in gut bacteria could revolutionize how we fight infections. Could one vaccine stop ETEC, Shigella, and more without antibiotics?
Scientists Discover Nickel Enzymes That Transfer Hydrides Between Molecules
A groundbreaking study upends decades of biochemical dogma. These nickel enzymes don't just move electrons—they shuttle hydrides between molecules with precision. Their hidden talents could revolutionize sustainable chemistry.
New Year Honours 2024: Knights, Dames and MBEs for UK's top innovators
A marathon-running rugby hero, a Wall Street trailblazer, and a space innovator lead this year's honours. Their stories redefine dedication—and inspire change.
Scientists discover new ARDS treatment pathway via immune cell modulation
Could rewiring immune cells save lives? A groundbreaking study reveals how the nervous system may hold the key to treating deadly lung inflammation.